Initial diagnostic test or to assess the general size of a tumor undergoing treatment, says study co-author Edwin Pratt, also of Memorial Sloan Kettering Cancer Center. It would be a quick and easy way to see if there’s something off … [that warrants] further investigation
The findings strengthen the case for the technology as a promising low-cost alternative that could expand access to nuclear imaging in hospitals, says Atonally Spinally, a preclinical imaging scientist at Experimental Imaging Center in Milan, Italy, who was not involved in the research
Initial diagnostic test or to assess the general size of a tumor undergoing treatment, says study co-author Edwin Pratt, also of Memorial Sloan Kettering Cancer Center. It would be a quick and easy way to see if there’s something off … [that warrants] further investigation
The findings strengthen the case for the technology as a promising low-cost alternative that could expand access to nuclear imaging in hospitals, says Atonally Spinally, a preclinical imaging scientist at Experimental Imaging Center in Milan, Italy, who was not involved in the research
Initial diagnostic test or to assess the general size of a tumor undergoing treatment, says study co-author Edwin Pratt, also of Memorial Sloan Kettering Cancer Center. It would be a quick and easy way to see if there’s something off … [that warrants] further investigation
The findings strengthen the case for the technology as a promising low-cost alternative that could expand access to nuclear imaging in hospitals, says Atonally Spinally, a preclinical imaging scientist at Experimental Imaging Center in Milan, Italy, who was not involved in the research
Initial diagnostic test or to assess the general size of a tumor undergoing treatment, says study co-author Edwin Pratt, also of Memorial Sloan Kettering Cancer Center. It would be a quick and easy way to see if there’s something off … [that warrants] further investigation
The findings strengthen the case for the technology as a promising low-cost alternative that could expand access to nuclear imaging in hospitals, says Atonally Spinally, a preclinical imaging scientist at Experimental Imaging Center in Milan, Italy, who was not involved in the research
Initial diagnostic test or to assess the general size of a tumor undergoing treatment, says study co-author Edwin Pratt, also of Memorial Sloan Kettering Cancer Center. It would be a quick and easy way to see if there’s something off … [that warrants] further investigation
The findings strengthen the case for the technology as a promising low-cost alternative that could expand access to nuclear imaging in hospitals, says Atonally Spinally, a preclinical imaging scientist at Experimental Imaging Center in Milan, Italy, who was not involved in the research
Initial diagnostic test or to assess the general size of a tumor undergoing treatment, says study co-author Edwin Pratt, also of Memorial Sloan Kettering Cancer Center. It would be a quick and easy way to see if there’s something off … [that warrants] further investigation
The findings strengthen the case for the technology as a promising low-cost alternative that could expand access to nuclear imaging in hospitals, says Atonally Spinally, a preclinical imaging scientist at Experimental Imaging Center in Milan, Italy, who was not involved in the research
You must be logged in to post a comment.